A new study details a promising virus-based therapy for glioblastoma, a highly aggressive form of brain cancer. The treatment involves injecting a modified oncolytic virus directly into the tumor. This virus selectively infects and kills cancer cells while simultaneously triggering a powerful, targeted immune response. Researchers report that in pre-clinical models, the therapy not only attacked the primary tumor but also trained the immune system to recognize and eliminate remaining cancer cells throughout the brain, potentially preventing recurrence. The approach represents a significant step forward in the challenging field of brain cancer immunotherapy. Read the full article at: https://www.sciencedaily.com/releases/2026/03/260319044708.htm